Evidence map›Paper›PMID 31798334›Full record

ArticleContemporary oncology (Poznan, Poland)2019

An evaluation of the construction of the device along with the software for digital archiving, sending the data, and supporting the diagnosis of cervical cancer.

Łukasz Lasyk, Jakub Barbasz, Paweł Żuk, Artur Prusaczyk, Tomasz Włodarczyk, Ewa Prokurat, Wojciech Olszewski, Mariusz Bidziński, Piotr Baszuk, Jacek Gronwald

Abstract read
In one paragraph

Article in Contemporary oncology (Poznan, Poland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Łukasz LasykDigitmed Sp. z o.o., Oleśnica, Poland.
Jakub BarbaszDigitmed Sp. z o.o., Oleśnica, Poland.
Paweł ŻukDigitmed Sp. z o.o., Oleśnica, Poland.
Artur PrusaczykDigitmed Sp. z o.o., Oleśnica, Poland.
Tomasz WłodarczykDigitmed Sp. z o.o., Oleśnica, Poland.
Ewa ProkuratDigitmed Sp. z o.o., Oleśnica, Poland.
Wojciech OlszewskiDepartment of Pathology, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.
Mariusz BidzińskiDepartment of Gynaecological Oncology, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.
Piotr BaszukDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jacek GronwaldCentrum Medical and Diagnostic Center Sp. z o.o., Siedlce, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is still an important cause of mortality among women in a number of countries. There are effective methods of prevention and early diagnosis, but they require well-trained medical professionals including cytologists. Within this project, we built a prototype of a new device together with implemented software using U-NET and CNN architectures of neural networks (ANN), to convert the currently used optical microscopes into fully independent scanning and evaluating systems for cytological samples. To evaluate the specificity and sensitivity of the system, 2058 (2000 normal and 58 abnormal samples) consecutive liquid-based cytology (LBC) samples were analysed. The observed sensitivity and specificity to distinguish normal and abnormal samples was 100%. We observed slight incompatibility in the evaluation of the type of abnormality. The use of ANN is promising for increasing the effectiveness of cervical screening. The low cost of neural network usage further increases the potential areas of application of the presented method. Further refinement of neural networks on a larger sample size is required to evaluate the software.

Indexed as

automatic evaluationcervical cancercytology

Identifiers

PMID31798334
PMCPMC6883966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.